Trial Site Detail

 

Drug:
CB-839 + Talazoparib
Trial:
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
Conditions: Solid Tumors
Trial Status:
Recruiting

 

Massachusetts General Hospital

55 Fruit Street     
Boston , MA 02114
USA

 

Principal Investigator:
Richard Lee, MD
Contact:
Contact: Richard Lee, MD 617-724-4000 rjlee@partners.org
Activation Status of this Site:
Active
Notes about this Site:
Massachusetts General Hospital Website:
http://www2.massgeneral.org/cancer/clinical_trials/adult/search_trials.asp

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.